BSF Enterprise Plc (LON: BSFA) shares jumped 18% after the US Patent and Trademark Office issued a Notice of Allowance covering key intellectual property behind its ETSYL® collagen technology.
BSF Enterprise targets luxury cars and robotics with materials deal
BSF Enterprise Plc (LON: BSFA) has entered a strategic partnership with SCHAKAU Managementberatung to commercialise its lab-grown leather in ultra-luxury vehicles and bio-engineered skin materials for humanoid and industrial robotics.
BSF Enterprise Signs Exclusive Global ETSYL® Skincare Commercialisation Deal
BSF Enterprise PLC (LON: BSFA) has signed heads of terms with SCHAKAU Managementberatung GmbH for the worldwide exclusive commercialisation of its proprietary bioactive peptide ETSYL® across cosmetics, skincare, dermocosmetics and
BSF Enterprise PLC (LON:BSFA) 3D Bio-Tissues Product Partnership Progress
BSF (LSE: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company and owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues (3DBT), provides an update on the Company’s partnership progress